Exchange: NASDAQ·Updated 04:56 PM EDT
BIVI logo

BIVI BioVie Inc

$1.26
$0.13
(9.49%)
Today
Closed $1.24
$0.02
(1.61%)
After Hours
EarningsNov 9
Mkt Cap$11.69M
Vol279,468.00

About BIVI

BioVie, Inc. is a biopharmaceutical company, which engages in discovery, development, and marketing drug therapies for neurological and neurodegenerative disorders, and liver disease. The company was founded on April 10, 2013 and is headquartered in Carson City, NV.
70

Bullish Sentiment

How do you feel about BIVI?

Rayvio_News_Filter
$BIVI 🏥 BioVie announced Phase 2 ADDRESS-LC trial results for bezisterim showing statistically significant improvements versus placebo in fatigue, post-exertional malaise, and objective cognitive measures in Long COVID patients with higher baseline symptom burden. Curated for market relevance
5
Itinerant
$BIVI I think that Do is a very straightforward guy, and I like that a lot. This is a core holding for me, and I expect it to succeed greatly. JMO
5
Itinerant
$BIVI What is the most likely financing in this difficult situation. I suspect that it is the NIH for Long Covid.
1
TJ12000
$BIVI disolve this pos gypsy scam company already....kong u dirtly greasball bald headed mofo
TJ12000
$BIVI gypsy scam.....here today gone with ur money tommorrow. She about summed up do-nkey cuong
TJ12000
$BIVI people are finally starting to understand not to trust gypsy companies. Took some convincing

Advertisement|Remove ads.